Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class

Related Research units

Bibliographical data

Original languageEnglish
ISSN0017-8748
DOIs
Publication statusPublished - 02.2020

Comment Deanary

Letter

PubMed 31872439